MedicarePartD.guide

A non-government resource built from CMS public data

SGLT2 inhibitors on every 2026 Louisiana Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in Louisiana cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
SGLT2 inhibitors by 2026 Louisiana Part D plan
DrugHumana Basic Rx Plan$0.00/moS5884-108Wellcare Value Script$5.70/moS4802-133Wellcare Classic$6.70/moS4802-012Humana Value Rx Plan$19.30/moS5884-200AARP Medicare Rx Saver from UHC$37.00/moS5921-366SilverScript Choice$44.70/moS5601-042HealthSpring Assurance Rx$48.40/moS5617-103HealthSpring Extra Rx$60.60/moS5617-371Humana Premier Rx Plan$113.70/moS5884-167AARP Medicare Rx Preferred from UHC$139.50/moS5921-402
JardianceempagliflozinTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 320%QL 30/30dTier 316%QL 30/30dTier 319%QL 30/30dTier 320%QL 30/30dTier 317%QL 30/30dTier 3$45.00QL 30/30dTier 315%QL 30/30d
FarxigadapagliflozinTier 325%QL 30/30dNot coveredNot coveredTier 320%QL 30/30dNot coveredTier 319%QL 30/30dTier 320%QL 30/30dTier 317%QL 30/30dTier 3$45.00QL 30/30dNot covered
dapagliflozingeneric FarxigaTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 320%QL 30/30dTier 316%QL 30/30dTier 319%QL 30/30dTier 320%QL 30/30dTier 317%QL 30/30dTier 3$45.00QL 30/30dTier 315%QL 30/30d
InvokanacanagliflozinNot coveredTier 440%QL 60/30dTier 428%QL 60/30dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
SteglatroertugliflozinNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
InpefasotagliflozinNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.